Stock WAVE WAVERLEY PHARMA INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Waverley Pharma Inc.

Equities

WAVE

CA94357L1058

Delayed Toronto S.E.
Other stock markets
 20:07:17 24/06/2024 BST 		5-day change 1st Jan Change
0.035 CAD 0.00% Intraday chart for Waverley Pharma Inc. 0.00% +40.00%
06-20 Waverley Pharma Inc. Elects James Kinley as Director CI
05-29 Waverley Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Waverley Pharma Announces Annual and Special Meeting Election Results
AQ
Waverley Pharma : Notice of meeting
PU
Waverley Pharma : Information circular
PU
Waverley Pharma Business Update
AQ
Waverley Pharma Announces Changes to Board of Directors
AQ
Waverley Pharma Business Update
AQ
Waverley Pharma Provides Business Update
AQ
Waverley Pharma Provides Update on its PARP-1 Inhibitor Program
AQ
Waverley Pharma : Announces $3,000,000 Credit Facility
AQ
Waverley Pharma : Announces Successful Tender Award for Pemetrexed with NHS England
AQ
Waverley Pharma : Announces Successful Tender Award for Capecitabine with NHS Scotland
AQ
Waverley Pharma : Announces Tentative ANDA Approval for Pemetrexed in the United States
AQ
Waverley Pharma Announces Listing on the Frankfurt Stock Exchange (FSE: 5GZ)
AQ
Waverley Pharma : Announces Signing of Term Sheet to Acquire Exclusive Rights to Market Six Generic Oncology Products in the United States
AQ
Waverley Pharma : Announces Grant of Market Authorization for Pemetrexed in Spain and Bortezomib in Italy
AQ
Waverley Pharma : Announces Grant of Market Authorization for Pemetrexed and Bortezomib in Multiple European Countries
AQ
Waverley Pharma : Announces Collaboration with Dr. David E. Herbert and the University of Manitoba for the Development of a Synthetic Library of Chloroquine Analogs to Treat COVID-19
AQ
Waverley Pharma : Announces Reliance on Relief from Filing Requirements for Annual Financial Statements
AQ
Waverley Pharma : Announces Appointment of New President and CEO
AQ
Waverley Pharma : Announces Executive Leadership Changes
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. WAVE Stock
  4. News Waverley Pharma Inc.
  5. Press Releases